A Randomised Controlled Clinical Trial of the Efficacy of HAART Intensification With Raltegravir in HIV Virally Suppressed Patients With Cognitive Impairment

Trial Profile

A Randomised Controlled Clinical Trial of the Efficacy of HAART Intensification With Raltegravir in HIV Virally Suppressed Patients With Cognitive Impairment

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 29 Jun 2016

At a glance

  • Drugs Raltegravir (Primary) ; Antiretrovirals
  • Indications HIV infections
  • Focus Therapeutic Use
  • Acronyms HANDral
  • Most Recent Events

    • 15 Jan 2014 Planned End Date changed to 1 Oct 2013 as reported in ClinicalTrials.gov record.
    • 15 Jan 2014 Status changed from not yet recruiting to discontinued as reported in ClinicalTrials.gov record.
    • 10 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top